Determinants of under-reporting of adverse drug reactions: a systematic review.
about
Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-AnalysisPatient Participation and the Use of Ehealth Tools for PharmacoviliganceMining electronic health records: towards better research applications and clinical careDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in NigeriaBias in spontaneous reporting of adverse drug reactions in JapanPredictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community PharmacistsDigital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public HealthCore requirements for successful data linkage: an example of a triangulation methodRecognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinantsComputing limits on medicine risks based on collections of individual case reportsPharmacovigilance Skills, Knowledge and Attitudes in our Future Doctors - A Nationwide Study in the Netherlands.Capture and documentation of coded data on adverse drug reactions: an overview.Data mining of the public version of the FDA Adverse Event Reporting SystemAssociation of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database.Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase(®).Educational sessions in pharmacovigilance: What do the doctors think?Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?Rheum rhaponticum Extract (ERr 731): Postmarketing Data on Safety Surveillance and Consumer ComplaintsItalian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine.Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.Magnitude of Antiretroviral Drug Toxicity in Adult HIV Patients in Ethiopia: A cohort study at seven teaching hospitals.The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil.Risk factors for adverse drug reactions in pediatric inpatients: a systematic review.Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.Impact of prescribed medications on patient safety in older people.Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospitalWarfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting systemAttitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages.An educational intervention's effect on healthcare professionals' attitudes towards pharmacovigilance.Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative studyBuilding the graph of medicine from millions of clinical narratives.Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in GujaratAdverse drug reaction reporting by doctors in a developing country: a case study from Ghana.
P2860
Q26752265-7B4FB8B4-6DF2-4749-9A13-9A7990A8BC9EQ26752684-92770CFC-2865-4F07-918D-45CC26AECE17Q27927409-5EFB9BA0-96EA-4926-83A1-81D3167F5DF2Q28544462-6907AFD8-A342-4C47-8E5E-572D7242CFA4Q28546900-485E7B45-C40B-4664-A0FF-63ECE0FF7531Q28552141-F40C9701-16C0-4888-801A-88D2C8FA73FDQ28588675-ACBB860F-5B80-401D-81F6-3391556B8270Q28596545-34817C6E-C2D3-44D8-A510-26D9F5C5914FQ28651397-1B8FE708-8385-4C8A-A6AF-86556B77B5A5Q28652138-BBEDF477-FADE-466B-812B-835F57045B6FQ30151585-35FE7E21-DE86-468C-9FED-60E9609706AFQ30632497-A467FEFE-5FE5-42A6-AEAC-F195028A64C8Q30651235-60C5D918-6EA9-429A-B099-88963699C1BFQ30803396-B48E9816-3840-4738-860F-35EAF3D8C027Q30844578-4A1BEC01-0158-4AA8-B05A-6C8B371DD478Q30844583-7B90F399-5553-4BE3-8FC7-EE25BE7C09A1Q30981333-AF963434-3647-49E7-8AF8-7F52F4409B2DQ30992133-B7E0B983-6855-4BD7-B6A0-CDCFBBBB75AEQ31030474-A4534CA1-1139-4CD6-8A9D-4FCA31454203Q31106486-3844D2E8-71B7-44E8-BCDE-3BB8341420F5Q31122724-4FEBB7B9-4E28-451A-84A9-10C56CE697D0Q31144143-8DB5C83E-EE37-421C-9B3D-DD5846746E69Q33488730-A099098F-3FBF-40A7-99B2-49DED53E5CF3Q33492598-2EADF7E6-C001-4FA3-925C-0B583B96C819Q33596144-6F250C5B-08A2-42E2-9FBB-5EE48B643205Q33737324-A02AA176-668D-40F1-B23A-F7D7304E73FAQ33757095-4A4A6693-CCD0-4F35-AB09-03A0FF05F934Q33815256-C0EF83D4-4ED6-42DE-9988-6B5CA19A8E6FQ33949432-891345BD-A535-4528-AF5B-A178490BBDEFQ34213612-9C63E702-3FA0-4307-9F21-E961DC66840BQ34389980-4B4E0C24-2453-4738-95AD-446E1932D16CQ34509106-5B7499CB-33F3-4C9A-B0DD-F36BDAB103CAQ34580625-29DBF95A-FADE-40C9-8C1F-AA21B2C33782Q34623753-B687D449-22B0-4E95-BB48-539CEABD02C2Q34726205-38F6AE31-4669-43CC-8AF9-A179E6DF5142Q34862636-8A8BED91-2466-42B5-AF65-219E1AC16D1EQ34940957-2F15DBAE-D11B-45F0-B7EA-1CF00BC6D013Q35066515-50AEB518-1E9D-4410-9D1C-14D8FDC7B875Q35089610-BCEE2D7E-CE45-4A57-909D-4D597CAF86B0Q35104563-546303D1-F3DF-4529-AE66-F4FBE4B8027D
P2860
Determinants of under-reporting of adverse drug reactions: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Determinants of under-reporting of adverse drug reactions: a systematic review.
@en
Determinants of under-reporting of adverse drug reactions: a systematic review.
@nl
type
label
Determinants of under-reporting of adverse drug reactions: a systematic review.
@en
Determinants of under-reporting of adverse drug reactions: a systematic review.
@nl
prefLabel
Determinants of under-reporting of adverse drug reactions: a systematic review.
@en
Determinants of under-reporting of adverse drug reactions: a systematic review.
@nl
P2860
P1433
P1476
Determinants of under-reporting of adverse drug reactions: a systematic review
@en
P2093
Adolfo Figueiras
Elena Lopez-Gonzalez
P2860
P356
10.2165/00002018-200932010-00002
P577
2009-01-01T00:00:00Z
P5875
P6179
1042490964